RELIGN’s Tricera is a revolutionary, advanced system that combines ablation/coagulation, tissue resection, bone cutting, and fluid management into one unique system
Relign Acquired by Zimmer Biomet

RELIGN’s Tricera is a revolutionary, advanced system that combines ablation/coagulation, tissue resection, bone cutting, and fluid management into one unique system
Koya Medical recently received FDA-clearance for the Dayspring™ product platform, a prescription only active wearable compression system for the treatment of lymphedema.
Nanochon’s technology replaces lost or damaged cartilage as an alternative to replacement surgeries.
Tangible Boost is a monthly treatment that restores the coating and maintains the wettability of Tangible’s proprietary rigid gas-permeable contact lenses.
ConsejoSano, recently selected for the Rosenman ADAPT program, raised $17 million in series B funding. The startup’s focus is to better communicate with patients based on their cultural background.
Kenota provides allergy specialists with a new approach to allergy testing, which takes less than 30 minutes and requires just a few drops of blood from a quick finger prick.
StimSite provides ob/gyns, general and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation.
Study to Enroll 600 Patients and Evaluate Real-World Clinical and Patient Reported Outcomes Across All Brain Tumor Types
– First Patient Enrolled by Vidant Health in Greenville, N.C.
Seven Startups Selected from Global Field, Matched with Three Leading U.S. Healthcare Payers for Support and Funding
The funding will advance R&D on the JAZBI™ bioresorbable implant system. The award also provides access to the NSW healthcare system resources and critical insights from NSW Health medical devices expert panel.